A Dose-escalation Study Using a Maximal Simultaneous Intraprostatic Boost With RapidArc Intensity Modulated Radiotherapy in Intermediate Risk Prostate Cancer.
Latest Information Update: 18 Sep 2021
At a glance
- Indications Prostate cancer
- Acronyms IMAX
Most Recent Events
- 11 Jul 2018 Biomarkers information updated
- 03 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 22 Oct 2009 New trial record